Hypertension and hypercholesterolemia are predictive factors associated with type 2 diabetes persistence after metabolic surgery: A prospective study.

[1]  Tao Zhang,et al.  Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance , 2022, Nutrients.

[2]  M. Davies,et al.  Type 2 diabetes , 2022, The Lancet.

[3]  D. Khalili,et al.  Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study , 2022, BMC Endocrine Disorders.

[4]  E. Halm,et al.  Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study. , 2021, JAMA internal medicine.

[5]  F. Rubino,et al.  Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes , 2021, Diabetes Care.

[6]  Jing Dong,et al.  The effects of bariatric surgery on dyslipidemia and insulin resistance in overweight patients with or without type 2 diabetes: a systematic review and network meta-analysis. , 2021, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[7]  Ahmed Rabiee,et al.  Factors associated with resolution of type-2 diabetes mellitus after sleeve gastrectomy in obese adults , 2021, Scientific Reports.

[8]  F. Rubino,et al.  Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial , 2021, The Lancet.

[9]  P. Schauer,et al.  Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery , 2020, Diabetes Care.

[10]  Deepak L. Bhatt,et al.  Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension , 2020, Annals of Internal Medicine.

[11]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[12]  A. Courcoulas,et al.  Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults. , 2019, The New England journal of medicine.

[13]  B. Richelsen,et al.  Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study , 2019, Diabetologia.

[14]  F. Rubino,et al.  Metabolic surgery for the treatment of type 2 diabetes in obese individuals , 2017, Diabetologia.

[15]  Deepak L. Bhatt,et al.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes , 2017, The New England journal of medicine.

[16]  A. De Gaetano,et al.  Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery , 2015, Diabetes Care.

[17]  A. De Gaetano,et al.  Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. , 2015, Annals of surgery.

[18]  C. Bouchard,et al.  Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. , 2014, JAMA.

[19]  Jon Gabrielsen,et al.  Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study. , 2014, The lancet. Diabetes & endocrinology.

[20]  A. Lacy,et al.  Long-Term Effects of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Surgery on Type 2 Diabetes Mellitus in Morbidly Obese Subjects , 2012, Annals of surgery.

[21]  J. Bunt,et al.  Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status. , 2012, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[22]  T. Donner,et al.  Update on Insulin Therapy for Type 2 Diabetes , 2012, The Journal of clinical endocrinology and metabolism.

[23]  R. Stubbs,et al.  A Model for Predicting the Resolution of Type 2 Diabetes in Severely Obese Subjects Following Roux-en Y Gastric Bypass Surgery , 2011, Obesity surgery.

[24]  A. Mooradian.  Dyslipidemia in type 2 diabetes mellitus , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[25]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[26]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003 .

[27]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.